About the REFLECT Trial (Study 304) REFLECT was an international, multicenter, randomized, open-label, non-inferiority Phase 3 study to compare the efficacy and safety of LENVIMA versus sorafenib as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results